Promethera Biosciences
Developing cutting-edge cell therapies and antibody-based medicines for the treatment of liver diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€30—46m (Dealroom.co estimates Dec 2019.)
Company register number 0809.788.365
Mont-Saint-Guibert Walloon Brabant (HQ)
Authorizing premium user...